Literature DB >> 30585464

[Toll-like Receptor 4/Nuclear Factor-κB Signaling in Synovial Tissue Is Involved in the Anti-inflammatory Effect of Moxibustion in Rats with Rheumatoid Arthritis].

Chuan-Ying Zhang1, Ling Hu2, Rong-Lin Cai2, Chuan-Yu Peng2, Juan Yuan3.   

Abstract

OBJECTIVE: To observe the effect of moxibustion on Toll-like receptor 4/nuclear factor-κB (TLR 4/NF-κB) signaling in the synovial tissue of the ankle joint in rats with rheumatoid arthritis (RA), so as to analyze its biological mechanism underlying improvement of RA.
METHODS: Fifty male SD rats were randomly divided into normal control, model, moxibustion, moxibustion + TLR 4 agonist, and moxibustion + TLR 4 antagonist groups (n=10 rats in each). The RA model was established by subcutaneous injection of Freund's complete adjuvant (FCA, 0.1 mL/rat) at the right hind-paw and by being raised in a wind (air fan blowing), cold (about 10 ℃) and wet (purling) environment for 20 days. After 3 days of modeling, mild moxibustion was applied to bilateral "Shenshu" (BL 23) and "Zusanli" (ST 36) for 20 minutes, once daily for successive 10 days. The TLR 4 agonist (lipopolysaccharide) or TLR 4 antagonist (TAK-242) (1 mg/mL) was separately administered via the tail vein 30 min before performing moxibustion every time in the agonist group and the antagonist group. The expression of NF-κB inhibitory factor ɑ (IκBɑ), IκB kinase complex β(IκKβ), myeloid differentiation factor 88 (MyD 88), TLR 4, and NF-κB p 65 proteins in the synovial tissue of the ankle joint was detected by using Western blot.
RESULTS: Following modeling, the girth of the swollen ankle joint was obviously bigger (P<0.01), and the expression levels of IκBɑ, IκKβ, TLR 4, MyD 88, and NF-κB p 65 proteins in the synovial tissue were considerably increased in the model group relevant to the normal control group (P<0.01). After moxibustion intervention, the girth of the swollen ankle joint and the expression levels of IκBɑ, IκKβ, TLR 4, MyD 88, and NF-κB p 65 proteins were significantly down-regulated in the moxibustion, moxibustion +TLR 4 agonist, moxibustion+TLR 4 antagonist groups compared with the model group (P<0.01, P<0.05). Comparison among the 3 moxibustion groups showed that the lowered levels of ankle-joint girth, and IκBɑ, IκKβ, TLR 4, MyD 88, and NF-κB p 65 expression were significantly smaller in the moxibustion+TLR 4 agonist group than in the simple moxibustion and moxibustion+TLR 4 antagonist groups (P<0.05,P<0.01). No significant differences were found between the moxibustion and moxibustion+TLR 4 antagonist groups in the decreased ankle joint girth and IκBɑ, IκKβ, TLR 4, MyD 88, and NF-κB p 65 expression levels (P>0.05), suggesting that activation of TLR 4 reduced the anti-inflammatory effect of moxibustion intervention.
CONCLUSION: Moxibustion can reduce the ankle joint swelling in RA rats, which may be closely associated with its effect in down-regulating the expression of IκBɑ, IκKβ, TLR 4, MyD 88, and NF-κB p 65 proteins and in inhibiting TLR 4/NF-κB signaling in the synovial tissue of the ankle joint.

Entities:  

Keywords:  Moxibustion; Myeloid differentiation factor 88; NF-κB p 65; Rheumatoid arthritis; Synovial tissue; Toll-like receptor 4 (TLR 4)

Mesh:

Substances:

Year:  2018        PMID: 30585464     DOI: 10.13702/j.1000-0607.180229

Source DB:  PubMed          Journal:  Zhen Ci Yan Jiu        ISSN: 1000-0607


  3 in total

1.  Effect of Moxibustion on the Serum Levels of MMP-1, MMP-3, and VEGF in Patients with Rheumatoid Arthritis.

Authors:  Zeyun Yu; Yingni Wang; Yuan Li; Chenxi Liao; Jingyang Dai; Yun Luo; Yuanzhang Hu; Siyu Tao; Jie Tang; Guanhua Chen; Ping Wu
Journal:  Evid Based Complement Alternat Med       Date:  2020-09-16       Impact factor: 2.629

Review 2.  Effect of Moxibustion on Inflammatory Cytokines in Animals with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.

Authors:  Yu-Mei Zhong; Bo- Cheng; Lin-Lin Zhang; Wen-Ting Lu; Ya-Nan Shang; Hai-Yan Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2020-09-08       Impact factor: 2.629

Review 3.  Moxibustion as an Adjuvant Therapy for Chronic Kidney Disease: A Systematic Review and Meta-Analysis of 23 Randomized Controlled Trials.

Authors:  Xu Zhou; Qingni Wu; Yanping Wang; Qing Ren; Weifeng Zhu; Ziqian Yao; Jianrong Chen
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-28       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.